Consortium gets $6.25 million to study pediatric immune-disorders

10/9/2009 | American City Business Journals

The Primary Immune Deficiency Treatment Consortium, led by the University of California, San Francisco, will use a $6.25 million NIH grant to study ways to improve treatment of life-threatening pediatric immune disorders. The consortium includes 13 pediatric research centers around the country, which serve 60% or more of patients with primary immunodeficiencies in North America.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC